Study reveals AI insights can predict development of disease a decade in advance
The study predicted the development of conditions including Alzheimer’s and heart disease
Read More
Tag: type 2 diabetes
International consortium identifies biomarkers for cardiovascular disease in diabetes
Type 2 diabetes is estimated to affect 462 million people worldwide
Read More
Bayer’s Kerendia approved in the US to slow CKD in type 2 diabetes patients
The approval is based on data from the Phase III FIDELIO-DKD renal outcomes study
Read More
FDA refuses Novo Nordisk’s once-weekly semaglutide
Company had been aiming for approval in type 2 diabetes
Read More
Lilly’s tirzepatide claims head-to-head trial win against injectable semaglutide
Tirzepatide demonstrated superior A1C and body weight reduction in type 2 diabetes
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
